Meredith Temple-Smith1, Lena Sanci2, Deborah Bateson3, Jane Hocking4, Jacqueline Coombe5, Jane Goller6, Alaina Vaisey7, Christopher Bourne8. 1. BSc, MPH, DHSc, Deputy Head, Director of Research Training, Department of General Practice, The University of Melbourne, Vic. 2. MBBS, PhD, FRACGP, Head, Department of General Practice, Melbourne Medical School, The University of Melbourne, Vic. 3. MA (Oxon), MSc (LSHTM), MB BS, Medical Director, Family Planning, NSW; Clinical Associate Professor, Discipline of Obstetrics, Gynaecology and Neonatology, Faculty of Medicine and Health, University of Sydney, NSW. 4. BAppSc, MPH, MHlthSc, PhD, Head, Sexual Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Vic. 5. BSocSc (Hons), PhD (Gender and Health), Research Officer, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Vic. 6. GradDip (Nursing), MPH, MHlthSc, PhD, Research Fellow, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Vic. 7. BSPH, MPH, Research Officer, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Vic. 8. MM (Sexual Health), FAChSHM, Head, NSW STI Programs Unit, Centre for Population Health, UNSW Sydney, NSW; Senior Staff Specialist, Sydney Sexual Health Centre, NSW; Conjoint Associate Professor, Sexual Health Program, Kirby Institute, UNSW Sydney, NSW.
Abstract
BACKGROUND: Chlamydia is the most commonly diagnosed bacterial sexually transmissible infection (STI) in Australia, with most infections diagnosed and managed in general practice. Often asymptomatic, left untreated it can cause serious reproductive complications in women. There is now global recognition of the importance of enhanced chlamydia case management to reduce the risk of repeat infection and minimise harms of pelvic inflammatory disease (PID). OBJECTIVE: The aim of this article is to provide evidence-based information and resources to help general practitioners engage in partner management and retesting as part of routine STI care, in accordance with Australia's Fourth National Sexually Transmissible Infections Strategy: 2018-2022, and to provide up-to-date evidence about anorectal chlamydia and other emerging concerns in women. DISCUSSION: Evidence-based information and strategies for partner management and retesting the index case are provided in this article, in addition to information regarding the detection of PID, screening and treatment of anorectal chlamydia, antimicrobial resistance, and testing and treatment in pregnancy.
BACKGROUND: Chlamydia is the most commonly diagnosed bacterial sexually transmissible infection (STI) in Australia, with most infections diagnosed and managed in general practice. Often asymptomatic, left untreated it can cause serious reproductive complications in women. There is now global recognition of the importance of enhanced chlamydia case management to reduce the risk of repeat infection and minimise harms of pelvic inflammatory disease (PID). OBJECTIVE: The aim of this article is to provide evidence-based information and resources to help general practitioners engage in partner management and retesting as part of routine STI care, in accordance with Australia's Fourth National Sexually Transmissible Infections Strategy: 2018-2022, and to provide up-to-date evidence about anorectal chlamydia and other emerging concerns in women. DISCUSSION: Evidence-based information and strategies for partner management and retesting the index case are provided in this article, in addition to information regarding the detection of PID, screening and treatment of anorectal chlamydia, antimicrobial resistance, and testing and treatment in pregnancy.
Authors: Nicole H T M Dukers-Muijrers; Ymke J Evers; Christian J P A Hoebe; Petra F G Wolffs; Henry J C de Vries; Bernice Hoenderboom; Marianne A B van der Sande; Janneke Heijne; Jeffrey D Klausner; Jane S Hocking; Jan van Bergen Journal: BMC Infect Dis Date: 2022-03-14 Impact factor: 3.090